Your session is about to expire
← Back to Search
Problem List Suggestion for Asthma (IQ-MAPLE Trial)
IQ-MAPLE Trial Summary
This trial is designed to improve care for patients with heart, lung and blood conditions by facilitating more accurate and complete problem list documentation.
- Asthma
- High Cholesterol
- Atrial Fibrillation
- Chronic Obstructive Pulmonary Disease
- Coronary Artery Disease
- Congestive Heart Failure
- Heart Attack
- Sickle Cell Disease
- Sleep Apnea
- Smoking
- Stroke
- Tuberculosis
- High Blood Pressure
IQ-MAPLE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowIQ-MAPLE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.IQ-MAPLE Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is this exploration currently admitting participants?
"Unfortunately, according to the information provided by clinicaltrials.gov this particular medical trial is not actively recruiting at this time. First posted on April 1st 2016 and last updated December 5th 2016, it remains closed for enrollment despite 4677 other studies accepting new patients right now."
How many facilities are managing this research endeavor?
"This clinical trial is being carried out in four different medical centres, including Brigham and Women's Hospital in Boston, Vanderbilt University Medical Center in Nashville, Holy Spirit Hospital in Camp Hill, as well as one other site."
Share this study with friends
Copy Link
Messenger